Influence of human immunodeficiency virus-infected maternal environment on development of infant interleukin-12 production

Journal of Infectious Diseases

Volumn 181, Issue 5, 2000, Pages 1590-1597

  Chougnet, Claire ^a   Kovacs, Andrea ^c   Baker, Robin ^d   Mueller, Brigitta U ^a,g   Luban, Naomi L C ^e   Liewehr, David J ^b   Steinberg, Seth M ^b   Thomas, Elaine K ^f   Shearer, Gene M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d INOVA FAIRFAX HOSPITAL FOR CHILDREN   (United States)

^e CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^f AMGEN INC   (United States)

^g BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN GP 39; INTERLEUKIN 10; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MONONUCLEAR CELL; NEWBORN PERIOD; PRIORITY JOURNAL; T LYMPHOCYTE; VERTICAL TRANSMISSION; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; CELLS, CULTURED; CHILD, PRESCHOOL; CYTOKINES; DISEASE TRANSMISSION, VERTICAL; FEMALE; FETAL BLOOD; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; INTERLEUKIN-10; INTERLEUKIN-12; LYMPHOCYTES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; REGRESSION ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA; ZIDOVUDINE;

EID: 0034048177     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315458     Document Type: Article

References (45)

1. 1. Adkins B. T-cell function in newborn mice and humans. Immunol Today 1999;20:330-5.
2. 2. Cohen SBA, Perez-Cruz I, Fallen P, Gluckman E, Madrigal JA. Analysis of the cytokine production by cord and adult blood. Hum Immunol 1999; 60:331-6.
3. 3. Clerici M, DePalma L, Roilides E, Baker R, Shearer CM. Analysis of T helper and antigen-presenting cell functions in cord blood and peripheral blood leukocytes from healthy children of different ages. J Clin Invest 1993;91:2829-36.
4. 4. Trivedi HN, HayGlass KT, Gangur V, Allardice JG, Embree JE, Plummer FA. Analysis of neonatal T cell and antigen presenting cell function. Hum Immunol 1997;57:69-79.
5. 5. Lee SM, Suen Y, Chang L, et al. Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-γ, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood monuclear cells. Blood 1996;88:945-54.
6. 6. Qian J, Lee SM, Suen Y, Knoppel E, Van de Ven C, Cairo MS. Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin 15 in upregulating antitumor immune activity and cytokine production in cord blood. Blood 1997;90: 3106-17.
7. 7. Luzuriaga K, Holmes D, Hereema A, Wong J, Panicali DL, Sullivan JL. HIV-1 specific cytotoxic T lymphocyte responses in the first year of life. J Immunol 1995;154:433-43.
8. 8. Riviere Y, Buseyne F Cytotoxic T lymphocyte generation capacity in early life with particular reference to HIV. Vaccine 1998;16:1420-2.
9. 9. Wasik TJ, Jagodzinski PP, Hyjek EM, et al. Diminished HIV-specific CTL activity is associated with lower type 1 and enhanced type 2 responses to HIV-specific peptides during perinatal HIV infection. J Immunol 1997; 158:6029-36.
10. 10. McFarland EJ, Harding PA, MaWhinney S, Schooley RT, Kuritzkes DR. In vitro effects of IL-12 on HIV-1-specific CTL lines from HIV-1-infected children. J Immunol 1998;161:513-9.
11. 11. Oxenius A, Karrer U, Zinkernagel RM, Hengartner H. IL-12 is not required for induction of type 1 cytokine responses in viral infections. J Immunol 1999;162:965-73.
12. 12. Trinchieri G. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-γ). Curr Opin Immunol 1997;9: 17-23.
13. 13. Kovacs A, Xu J, Rasheed S, et al. Comparison of a rapid nonisotopic polymerase chain reaction assay with four commonly used methods for the early diagnosis of human immunodeficiency virus type 1 infection in neonates and children. Pediatr Infect Dis J 1995;14:948-54.
14. 14. Chougnet C, Fowke KR, Mueller BU, et al. Protease inhibitor and triple-drug therapy: cellular immune parameters are not restored in pediatric AIDS patients after 6 months of therapy. AIDS 1998;12:2397-406.
15. 15. Fanslow WC, Srinivasan S, Paxton R, Gibson MG, Spriggs MK, Armitage RJ. Structural characteristics or CD40 ligand that determine biological function. Semin Immunol 1994;6:267-78.
16. 16. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988;75:800-2.
17. 17. Chougnet C, Wynn TA, Clerici M, et al. Molecular analysis of decreased IL-12 production in individuals infected with the human immunodeficiency virus. J Infect Dis 1996;174:46-53.
18. 18. Chougnet C, Thomas E, Landay AL, et al. CD40 Ligand and IFN-γ synergistically restore IL-12 production in HIV-infected patients. Eur J Immunol 1998;28:646-56.
19. 19. Harrison TS, Levitz SM. Priming with IFN-γ restores deficient IL-12 production by peripheral blood mononuclear cells from HIV-seropositive donors. J Immunol 1997;158:459-63.
20. 20. Johnston RB. Function and cell biology of neutrophils and mononuclear phagocytes in the newborn infant. Vaccine 1998;16:1363-8.
21. 21. Suen Y, Lee SM, Qian J, Van de Ven C, Cairo MS. Dysregulation of lymphokine production in the neonate and its impact on neonatal cell mediated immunity. Vaccine 1998;16:1336-77.
22. 22. Barrios C, Brawand P, Berney M, Brandt C, Lambert PH, Siegrist CA. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a TH2-biased pattern which persists after adult boosting. Eur J Immunol 1996;26: 1489-96.
23. 23. Barrios C, Brandt C, Berney M, Lambert PH, Siegrist CA. Partial correction of the TH2/TH1 imbalance in neonatal murine responses to vaccine antigens through selective adjuvant effects. Eur J Immunol 1996;26:2666-70.
24. 24. Yang LP, Byun DG, Demeure CE, Vezzio N, Delespesse G. Default development of cloned human naive CD4 T cells into IL-4 and IL-5 producing effector cells. Eur J Immunol 1995;25:3517-9.
25. 25. Malhotra I, Ouma J, Wamachi A, et al. In utero exposure to helminth and mycobacterial antigens generates cytokine responses similar to that observed in adults. J Clin Invest 1997;99:1759-66.
26. 26. Prescott SL, Macaubas C, Holt BJ, et al. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol 1998;160: 4730-7.
27. 27. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993;14:353-6.
28. 28. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997;18:478-82.
29. 29. Kampalath B, Cleveland RP, Kass L. Reduced CD4 and HLA-DR expression on neonatal monocytes. Clin Immunol Immunopathol 1998;87:93-100.
30. 30. Taoufik Y, Lantz O, Wallon C, Charles A, Dussaix E, Delfraissy JF. Human immunodeficiency virus gp120 inhibits interleukin-12 secretion by human monocytes: an indirect interleukin-10-mediated effect. Blood 1997;89: 2842-8.
31. 31. Ito M, Ishida T, He L, et al. HIV type 1 Tat protein inhibits interleukin 12 by human peripheral blood mononuclear cells. AIDS Res Hum Retroviruses 1998;14:845-9.
32. + lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers. Clin Diagn Lab Immunol 1997;4:358-61.
33. 33. Piccinni MP, Beloni L, Giannarini L, et al. Abnormal production of T helper 2 cytokines interleukin-4 and interleukin-5 by T cells from newborns with atopic parents. Eur J Immunol 1996;26:2293-8.
34. + T-cell responses. Immunol Today 1996;17:410-14.
35. 35. Marodi L, Kaposzta R, Campbell DE, Polin RA, Csongor J, Johnston RB. Candidacidal mechanisms in the human neonate. Impaired IFN-gamma activation of macrophages in newborn infants. J Immunol 1994;153: 5643-9.
36. 36. Zola H, Fusco M, Macardle PJ, Flego L, Roberton D. Expression of cytokine receptors by human cord blood lymphocytes: comparison with adult blood lymphocytes. Pediatr Res 1995;38:397-403.
37. 37. Brugnoni D, Airo P, Graf D, et al. Ineffective expression of CD40 ligand on cord blood T cells may contribute to poor immunoglobulin production in the newborn. Eur J Immunol 1994;24:1919-24.
38. 38. Nonoyama S, Penix LA, Edwards CP, et al. Diminished expression of CD40 ligand by activated neonatal T cells. J Clin Invest 1995;95:66-75.
39. 39. Durandy A, De Saint Basile G, Lisowska-Grospierre B, et al. Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns. J Immunol 1995;154:1560-8.
40. 40. Splawski JB, Nishioka J, Nishioka Y, Lipsky PE. CD40 ligand is expressed and functional on activated neonatal T cells. J Immunol 1996;156:119-27.
41. 41. Hyjek E, Lischner HW, Hyslop T, et al. Cytokine patterns during progression to AIDS in children with perinatal HIV infection. J Immunol 1995;155: 4060-71.
42. 42. Gans HA, Maldonado Y, Yasukawa LL, et al. IL-12, IFN-γ and T cell proliferation to measles in immunized infants. J Immunol 1999;162: 5569-75.
43. 43. Ota MOC, O'Donovan D, Marchant A, et al. HIV-negative infants born to HIV-1 but not HIV-2 positive mothers fail to develop a Bacillus Calmette-Guerin scar. AIDS 1999;13:996-8.
44. 44. Krasinski K, Borkowsky W. Measles and measles immunity in children infected with human immunodeficiency virus. JAMA 1989;261:2512-6.
45. 45. Brena AE, Cooper ER, Cabral HJ, Pelton SI. Antibody response to measles and rubella vaccine by children with HIV infection. J Acquir Immune Defic Syndr 1993;6:1125-9.